Ofloxacin Export Market Intelligence: India's 1094 Suppliers Shipping to 180 Countries — TransData Nexus 2026

Q: Who are the top ofloxacin exporters from India?

The top ofloxacin exporters from India are: 1. DR.REDDY'S LABORATORIES LTD — $42.0M (14.2% market share); 2. DR REDDYS LABORATORIES LIMITED — $29.8M (10.1% market share); 3. MACLEODS PHARMACEUTICALS LTD — $21.5M (7.3% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $19.9M (6.7% market share); 5. MICRO LABS LIMITED — $8.4M (2.8% market share). Together they account for 41.2% of India's total ofloxacin export value.

Q: What is the total export value of ofloxacin from India?

The total export value of ofloxacin from India is $295.2M USD, recorded across 15,000 shipment transactions from 1094 active exporters to 180 destination countries. The average shipment value is $19.7K.

Q: Which countries import ofloxacin from India?

India exports ofloxacin to 180 countries worldwide. The top importing countries are: UNITED STATES (39.2% share, $115.8M), VIETNAM (6.8% share, $20.0M), RUSSIA (4.5% share, $13.3M), NIGERIA (4.5% share, $13.3M), FRANCE (3.0% share, $8.7M). These five markets account for 57.9% of total export value.

Q: What is the HS code for ofloxacin exports from India?

The primary HS code for ofloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ofloxacin exports from India?

The average unit price for ofloxacin exports from India is $13.41 USD per unit, with prices ranging from $0.01 to $10480.89 depending on formulation, packaging, and order volume. The total market is valued at $295.2M across 15,000 shipments.

Q: Which ports handle ofloxacin exports from India?

The primary ports for ofloxacin exports from India are SAHAR AIR CARGO ACC (INBOM4) (12.3% of shipments), DELHI AIR CARGO ACC (INDEL4) (10.0% of shipments), SAHAR AIR (8.6% of shipments), NHAVA SHEVA SEA (INNSA1) (8.4% of shipments), DELHI AIR (6.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ofloxacin?

India is one of the world's leading exporters of ofloxacin due to its large base of 1094 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ofloxacin to 180 countries, demonstrating 92% global market coverage.

Q: What certifications do Indian ofloxacin exporters need?

Indian ofloxacin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ofloxacin from India?

There are 3,093 registered buyers importing ofloxacin from India, spread across 180 countries. The repeat buyer rate is 57.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ofloxacin supplier from India?

DR.REDDY'S LABORATORIES LTD is the leading ofloxacin exporter from India with a market share of 14.2% and total export value of $42.0M across 74 shipments. The top 5 suppliers together control 41.2% of total export value.

Suresh Sormare

Ofloxacin

India Pharmaceutical Trade Intelligence

$295.2M1,094 Suppliers180 CountriesHS 30049099

ExportsIndia → UNITED STATES39.2%India → VIETNAM6.8%

ImportsMALTA → India$59.6M CHINA → India$17.1M

#1 Buyer: DR REDDYS

Ofloxacin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ofloxacin to the World

Between 2022 and 2026, India exported $295.2M worth of ofloxacin across 15,000 verified shipments to 180 countries — covering 92% of world markets in the Advanced Antibiotics segment. The largest destination is UNITED STATES (39.2%). DR.REDDY'S LABORATORIES LTD leads with a 14.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ofloxacin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ofloxacin export data snapshot — $295.2M · 1094 exporters · 180 countriesTransData Nexus · Indian Customs Data

Top Ofloxacin Exporters from India

1094 active exporters · Ranked by export value

View all 1094 →

Top Ofloxacin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	DR.REDDY'S LABORATORIES LTD	$42.0M	74	2	14.2%
2	DR REDDYS LABORATORIES LIMITED

Top Countries Importing Ofloxacin from India

180 destination markets · Ranked by import value

All 180 countries →

Top Countries Importing Ofloxacin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$115.8M	39.2%
2	VIETNAM	$20.0M	6.8%
3	RUSSIA	$13.3M	4.5%
4	NIGERIA	$13.3M	4.5%
5	FRANCE	$8.7M	3.0%
6	SIERRA LEONE	$5.7M	1.9%
7	TURKEY	$5.6M	1.9%
8	KENYA	$5.5M	1.8%
9	UZBEKISTAN	$5.2M	1.8%
10	ETHIOPIA	$4.9M	1.6%

UNITED STATES is India's largest ofloxacin export destination, absorbing 39.2% of total exports worth $115.8M. The top 5 importing countries — UNITED STATES, VIETNAM, RUSSIA, NIGERIA, FRANCE — together account for 57.9% of India's total ofloxacin export value. The remaining 175 destination countries collectively receive the other 42.1%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Ofloxacin to India?

29 origin countries · Total import value: $79.3M

India imports ofloxacin from 29 countries with a combined import value of $79.3M. The largest supplier is MALTA ($59.6M, 27 shipments), followed by CHINA and ISRAEL. All values are from Indian Customs (DGFT) import records.

Countries Supplying Ofloxacin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	MALTA	$59.6M	27	75.2%
2	CHINA	$17.1M	5	21.6%
3	ISRAEL	$1.7M	3	2.2%
4	UNITED STATES	$639.9K	109	0.8%
5	ITALY	$94.7K	3	0.1%
6	BELGIUM	$58.6K	4	0.1%
7	SWITZERLAND	$24.4K	1	0.0%
8	GERMANY	$21.8K	23	0.0%
9	JAPAN	$18.3K	6	0.0%
10	BRAZIL	$6.2K	4	0.0%

Showing top 10 of 29 origin countries

MALTA is the largest supplier of ofloxacin to India, accounting for 75.2% of total import value. The top 5 origin countries — MALTA, CHINA, ISRAEL, UNITED STATES, ITALY — together supply 99.8% of India's ofloxacin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Ofloxacin — Export Intelligence Video

Visual overview of India's ofloxacin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's ofloxacin pharmaceutical import and export market — $295.2M in total trade, 1094 verified manufacturers, and 180 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Ofloxacin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, ofloxacin has been approved through multiple Abbreviated New Drug Applications (ANDAs). The original approval for Floxin (ofloxacin) tablets was granted to R.W. Johnson Pharmaceutical Research Institute on December 13, 1991. Subsequent approvals include Floxin Otic (ofloxacin) solution by Daiichi Pharmaceutical on December 16, 1997. These approvals indicate a well-established regulatory pathway for ofloxacin in the U.S. market.

Given the substantial volume of ofloxacin exports from India to the U.S., with 1,094 active Indian exporters and a repeat buyer rate of 57.4%, it is imperative for exporters to ensure compliance with FDA regulations. This includes adherence to current Good Manufacturing Practices (cGMP) and maintaining vigilance for any FDA import alerts that may affect market access.

2EU & UK Regulatory Framework

In the European Union, ofloxacin is subject to marketing authorization by national competent authorities. A Periodic Safety Update Report (PSUR) single assessment for systemic use of ofloxacin was conducted, leading to a variation in the product information to include delirium as a potential adverse effect. This assessment was finalized in January 2022. Manufacturers must comply with EU Good Manufacturing Practice (GMP) guidelines to ensure product quality and safety.

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization and monitoring of medicinal products, including ofloxacin. Compliance with MHRA regulations and GMP standards is essential for market access in the UK.

3WHO Essential Medicines & Global Standards

Ofloxacin is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in treating bacterial infections. It is also listed in major pharmacopoeias such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), reflecting its global acceptance and standardized quality requirements.

4India Regulatory Classification

In India, ofloxacin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including ofloxacin, to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceuticals, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for ofloxacin have expired, leading to a competitive generic market. This has facilitated the entry of multiple manufacturers, contributing to the substantial export volume from India.

6Recent Industry Developments

In January 2022, the European Medicines Agency (EMA) concluded a PSUR single assessment for systemic use of ofloxacin, resulting in an update to the product information to include delirium as a potential adverse effect. This underscores the importance of continuous pharmacovigilance and the need for manufacturers to update safety information accordingly.

In March 2025, the FDA approved a new generic version of ofloxacin otic solution, expanding treatment options for otic infections. This approval reflects the ongoing demand for ofloxacin formulations and the dynamic nature of the pharmaceutical market.

These developments highlight the evolving regulatory landscape and the necessity for exporters to stay informed about changes that may impact market access and compliance requirements.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Ofloxacin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Ofloxacin, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of these critical components are sourced from China, highlighting a significant dependency. This reliance exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or production issues within China.

Recent events have underscored this vulnerability. In October 2025, the U.S. Pharmacopeia reported that 58% of KSMs used for U.S.-approved APIs are solely sourced from a single country, predominantly China. Such concentration poses risks of supply shortages and price volatility, which can directly impact the availability and cost of Ofloxacin exports from India.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Ofloxacin from India account for 41.2% of the total export value, with DR. REDDY'S LABORATORIES LTD leading at a 14.2% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact the overall supply chain.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic manufacturing of APIs and reduce dependency on imports. While this initiative is a positive step, its full impact on diversifying the supplier base and enhancing supply chain resilience remains to be seen.

Access Complete Ofloxacin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 15,000 transactions across 180 markets.

Request Demo View Pricing

Frequently Asked Questions — Ofloxacin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ofloxacin exporters from India?

The leading ofloxacin exporters from India are DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, and 12 others. DR.REDDY'S LABORATORIES LTD leads with 14.2% market share ($42.0M). The top 5 suppliers together control 41.2% of total export value.

What is the total export value of ofloxacin from India?

The total export value of ofloxacin from India is $295.2M, recorded across 15,000 shipments from 1094 active exporters to 180 countries. The average shipment value is $19.7K.

Which countries import ofloxacin from India?

India exports ofloxacin to 180 countries. The top importing countries are UNITED STATES (39.2%), VIETNAM (6.8%), RUSSIA (4.5%), NIGERIA (4.5%), FRANCE (3.0%), which together account for 57.9% of total export value.

What is the HS code for ofloxacin exports from India?

The primary HS code for ofloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ofloxacin

Ofloxacin

How India Exports Ofloxacin to the World

Top Ofloxacin Exporters from India

Top Countries Importing Ofloxacin from India

Who Supplies Ofloxacin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Ofloxacin — Export Intelligence Video

Regulatory Landscape — Ofloxacin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Ofloxacin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ofloxacin Trade Intelligence

Frequently Asked Questions — Ofloxacin Exports from India

Who are the top ofloxacin exporters from India?

What is the total export value of ofloxacin from India?

Which countries import ofloxacin from India?

What is the HS code for ofloxacin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ofloxacin exports from India?

Which ports handle ofloxacin exports from India?

Why is India a leading exporter of ofloxacin?

What certifications do Indian ofloxacin exporters need?

How many buyers import ofloxacin from India?

What is the market share of the top ofloxacin exporter from India?

Analysis Methodology